These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 7507123)

  • 1. Use of leuprolide acetate response patterns in the early diagnosis of pubertal disorders: comparison with the gonadotropin-releasing hormone test.
    Ibáñez L; Potau N; Zampolli M; Virdis R; Gussinyé M; Carrascosa A; Saenger P; Vicens-Calvet E
    J Clin Endocrinol Metab; 1994 Jan; 78(1):30-5. PubMed ID: 7507123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test.
    Garibaldi LR; Aceto T; Weber C; Pang S
    J Clin Endocrinol Metab; 1993 Apr; 76(4):851-6. PubMed ID: 8473395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.
    Neely EK; Hintz RL; Parker B; Bachrach LK; Cohen P; Olney R; Wilson DM
    J Pediatr; 1992 Oct; 121(4):634-40. PubMed ID: 1403402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls.
    Brito VN; Latronico AC; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4338-42. PubMed ID: 15356030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual dimorphism in the maturation of the pituitary-gonadal axis, assessed by GnRH agonist challenge.
    Potau N; Ibáñez L; Sentis M; Carrascosa A
    Eur J Endocrinol; 1999 Jul; 141(1):27-34. PubMed ID: 10407219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maturation of the normal pituitary-testicular axis, as assessed by gonadotropin-releasing hormone agonist challenge.
    Ghai K; Rosenfield RL
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1336-40. PubMed ID: 8200935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of leuprolide acetate 3-month depot 11.25 milligrams or 30 milligrams for the treatment of central precocious puberty.
    Lee PA; Klein K; Mauras N; Neely EK; Bloch CA; Larsen L; Mattia-Goldberg C; Chwalisz K
    J Clin Endocrinol Metab; 2012 May; 97(5):1572-80. PubMed ID: 22344198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged pulsatile administration of luteinizing hormone-releasing hormone in prepubertal children: diagnostic and physiologic aspects.
    Delemarre-van de Waal HA; Van den Brande JL; Schoemaker J
    J Clin Endocrinol Metab; 1985 Nov; 61(5):859-67. PubMed ID: 3930552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
    J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin releasing hormone agonist (nafarelin) test to differentiate gonadotropin deficiency from constitutionally delayed puberty in teen-age boys--a clinical research center study.
    Ghai K; Cara JF; Rosenfield RL
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2980-6. PubMed ID: 7559884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotropin-releasing hormone pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins.
    Apter D; Bützow TL; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1993 Apr; 76(4):940-9. PubMed ID: 8473410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between spontaneous gonadotropin concentration profiles and gonadotropin response to low-dose gonadotropin-releasing hormone in prepubertal and early pubertal boys and patients with hypogonadotropic hypogonadism: assessment by using ultrasensitive, time-resolved immunofluorometric assay.
    Goji K; Tanikaze S
    Pediatr Res; 1992 May; 31(5):535-9. PubMed ID: 1603636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
    Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y
    J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion.
    Sklar CA; Rothenberg S; Blumberg D; Oberfield SE; Levine LS; David R
    J Clin Endocrinol Metab; 1991 Oct; 73(4):734-8. PubMed ID: 1909701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin-releasing hormone testing in premature thelarche.
    Choubtum L; Mahachoklertwattana P; Sriphrapradang A; Preeyasombat C
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S33-8. PubMed ID: 10730515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteinizing Hormone Secretion during Gonadotropin-Releasing Hormone Stimulation Tests in Obese Girls with Central Precocious Puberty.
    Lee HS; Yoon JS; Hwang JS
    J Clin Res Pediatr Endocrinol; 2016 Dec; 8(4):392-398. PubMed ID: 27215137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels.
    Andersson AM; Juul A; Petersen JH; Müller J; Groome NP; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3976-81. PubMed ID: 9398699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
    Ibañez L; Hall JE; Potau N; Carrascosa A; Prat N; Taylor AE
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overnight luteinizing and follicle stimulating hormone profiles during GnRHa treatment in short girls born small for gestational age.
    van der Kaay DC; de Jong FH; Laven JS; Hokken-Koelega AC
    J Pediatr Endocrinol Metab; 2009 Feb; 22(2):161-9. PubMed ID: 19449673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.